Chinese General Practice ›› 2023, Vol. 26 ›› Issue (11): 1330-1339.DOI: 10.12114/j.issn.1007-9572.2022.0721
• Original Research • Previous Articles Next Articles
Received:
2022-09-23
Revised:
2023-01-11
Published:
2023-04-15
Online:
2023-01-31
Contact:
MA Dong, ZHAO Yongbo
About author:
通讯作者:
马冬, 赵永波
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0721
组别 | 例数 | 年龄( | 性别(男/女) | 高血压〔n(%)〕 | 冠心病〔n(%)〕 | 吸烟〔n(%)〕 | 饮酒〔n(%)〕 | 体温( | 心率( | 收缩压( | 舒张压( | 住院时长〔M(P25,P75),d〕 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
总患者 | 206 | 51.6±11.5 | 139/67 | 150(72.8) | 9(4.4) | 96(46.6) | 111(53.9) | 36.6±0.5 | 79±18 | 135±27 | 75±18 | 18.0(12.8,26.0) |
T1组 | 69 | 50.8±11.9 | 48/21 | 54(78.3) | 5(7.2) | 39(56.5) | 43(62.3) | 36.7±0.5 | 79±19 | 138±24 | 78±17 | 19.0(14.0,28.0) |
T2组 | 70 | 51.9±10.9 | 46/24 | 45(64.3) | 2(2.9) | 28(40.0) | 34(48.6) | 36.5±0.5 | 79±18 | 134±27d | 72±19 | 17.0(11.5,23.0) |
T3组 | 67 | 52.3±11.7 | 45/22 | 51(76.1) | 2(3.0) | 67(43.3) | 34(50.7) | 36.8±0.5e | 79±16 | 132±27de | 74±17 | 19.0(11.0,28.3) |
检验统计量值 | 0.309a | 0.239b | 3.946b | 2.057b | 4.251b | 3.036b | 3.713a | 0.011a | 3.108a | 1.946a | 1.985c | |
P值 | 0.735 | 0.887 | 0.137 | 0.357 | 0.119 | 0.219 | 0.026 | 0.989 | 0.047 | 0.146 | 0.371 | |
组别 | 丙氨酸氨基转移酶〔M(P25,P75),U/L〕 | 天冬氨酸氨基转移酶〔M(P25,P75),U/L〕 | 肌酐〔M(P25,P75),μmol/L〕 | 尿素氮〔M(P25,P75),mmol/L〕 | 血糖〔M(P25,P75),mmol/L〕 | 血小板计数〔M(P25,P75),×109/L〕 | 白细胞计数〔M(P25,P75),×109/L〕 | 红细胞计数〔M(P25,P75),×109/L〕 | 血红蛋白〔M(P25,P75),mmol/L〕 | |||
总患者 | 21.8(15.5,33.2) | 35.6(19.9,66.9) | 80.0(63.0,110.0) | 6.2(4.7,7.7) | 7.2(6.2,8.6) | 165.0(134.0,202.5) | 11.3(9.2,14.1) | 4.1(3.8,4.5) | 127.1(115.5,136.4) | |||
T1组 | 20.0(15.4,29.1) | 36.1(18.6,67.3) | 87.0(66.5,118.5) | 6.5(4.7,8.9) | 7.7(6.2,9.5) | 168.0(131.0,209.0) | 11.5(9.0,13.5) | 4.1(3.8,4.4) | 125.9(113.9,133.8) | |||
T2组 | 22.0(16.2,32.7) | 32.9(18.4,59.7) | 81.0(63.0,108.5) | 5.4(4.6,7.7) | 7.2(6.2,7.9) | 167.0(142.0,167.0) | 11.7(9.4,14.5) | 4.2(3.7,4.5) | 128.1(113.5,136.3) | |||
T3组 | 22.1(14.6,36.9) | 40.7(22.5,67.2) | 77.0(63.0,103.3) | 6.2(5.3,7.6) | 7.0(6.3,8.6) | 158.0(127.0,194.2) | 10.8(9.1,14.3) | 4.1(3.8,4.6) | 126.9(116.7,139.3) | |||
检验统计量值 | 0.409c | 1.756c | 2.788c | 2.831c | 3.418c | 3.135c | 2.087c | 0.311c | 0.734c | |||
P值 | 0.815 | 0.416 | 0.248 | 0.243 | 0.181 | 0.209 | 0.352 | 0.856 | 0.693 | |||
组别 | 中性粒细胞计数〔M(P25,P75),×109/L〕 | 淋巴细胞计数〔M(P25,P75),×109/L〕 | 单核细胞计数〔M(P25,P75),×109/L〕 | 体外循环时间>4 h〔n(%)〕 | 主动脉阻断时间( | 术前发生灌注不足〔n(%)〕 | 阴离子间隙( | 血K+ 〔M(P25,P75),mmol/L〕 | 血Na+ 〔M(P25,P75),mmol/L〕 | 血Ca2+〔M(P25,P75),mmol/L〕 | ||
总患者 | 9.7(7.5,12.4) | 0.9(0.6,1.2) | 0.7(0.5,0.9) | 74(35.9) | 119.9±20.6 | 53(25.7) | 15.2±3.9 | 4.0(3.4,4.0) | 139.0(136.0,141.0) | 2.2(2.1,2.3) | ||
T1组 | 9.8(7.1,11.8) | 0.9(0.6,1.4) | 0.7(0.5,1.0) | 23(33.3) | 125.6±27.6 | 22(31.9) | 16.1±3.2 | 3.8(3.2,4.0) | 136.0(134.0,139.0) | 2.1(2.0,2.3) | ||
T2组 | 10.1(7.4,12.8) | 0.9(0.6,1.3) | 0.7(0.6,0.9) | 27(38.6) | 119.8±24.3 | 17(24.3) | 15.4±3.9 | 4.0(3.6,4.1) | 139.0(137.0,140.0)d | 2.2(2.1,2.3) | ||
T3组 | 9.6(7.9,12.8) | 0.8(0.6,0.9) | 0.6(0.5,0.9) | 24(35.8) | 121.4±21.1 | 14(20.9) | 14.1±4.4d | 4.0(3.4,4.1) | 140.0(139.0,143.0)d | 2.1(2.0,2.3) | ||
检验统计量值 | 2.350c | 4.241c | 2.441c | 0.415b | 2.601a | 2.263b | 4.387a | 4.383c | 57.384c | 5.782c | ||
P值 | 0.309 | 0.120 | 0.295 | 0.813 | 0.310 | 0.322 | 0.014 | 0.112 | 0.001 | 0.056 |
Table 1 Baseline characteristics of three groups of acute Stanford type A aortic dissection patients
组别 | 例数 | 年龄( | 性别(男/女) | 高血压〔n(%)〕 | 冠心病〔n(%)〕 | 吸烟〔n(%)〕 | 饮酒〔n(%)〕 | 体温( | 心率( | 收缩压( | 舒张压( | 住院时长〔M(P25,P75),d〕 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
总患者 | 206 | 51.6±11.5 | 139/67 | 150(72.8) | 9(4.4) | 96(46.6) | 111(53.9) | 36.6±0.5 | 79±18 | 135±27 | 75±18 | 18.0(12.8,26.0) |
T1组 | 69 | 50.8±11.9 | 48/21 | 54(78.3) | 5(7.2) | 39(56.5) | 43(62.3) | 36.7±0.5 | 79±19 | 138±24 | 78±17 | 19.0(14.0,28.0) |
T2组 | 70 | 51.9±10.9 | 46/24 | 45(64.3) | 2(2.9) | 28(40.0) | 34(48.6) | 36.5±0.5 | 79±18 | 134±27d | 72±19 | 17.0(11.5,23.0) |
T3组 | 67 | 52.3±11.7 | 45/22 | 51(76.1) | 2(3.0) | 67(43.3) | 34(50.7) | 36.8±0.5e | 79±16 | 132±27de | 74±17 | 19.0(11.0,28.3) |
检验统计量值 | 0.309a | 0.239b | 3.946b | 2.057b | 4.251b | 3.036b | 3.713a | 0.011a | 3.108a | 1.946a | 1.985c | |
P值 | 0.735 | 0.887 | 0.137 | 0.357 | 0.119 | 0.219 | 0.026 | 0.989 | 0.047 | 0.146 | 0.371 | |
组别 | 丙氨酸氨基转移酶〔M(P25,P75),U/L〕 | 天冬氨酸氨基转移酶〔M(P25,P75),U/L〕 | 肌酐〔M(P25,P75),μmol/L〕 | 尿素氮〔M(P25,P75),mmol/L〕 | 血糖〔M(P25,P75),mmol/L〕 | 血小板计数〔M(P25,P75),×109/L〕 | 白细胞计数〔M(P25,P75),×109/L〕 | 红细胞计数〔M(P25,P75),×109/L〕 | 血红蛋白〔M(P25,P75),mmol/L〕 | |||
总患者 | 21.8(15.5,33.2) | 35.6(19.9,66.9) | 80.0(63.0,110.0) | 6.2(4.7,7.7) | 7.2(6.2,8.6) | 165.0(134.0,202.5) | 11.3(9.2,14.1) | 4.1(3.8,4.5) | 127.1(115.5,136.4) | |||
T1组 | 20.0(15.4,29.1) | 36.1(18.6,67.3) | 87.0(66.5,118.5) | 6.5(4.7,8.9) | 7.7(6.2,9.5) | 168.0(131.0,209.0) | 11.5(9.0,13.5) | 4.1(3.8,4.4) | 125.9(113.9,133.8) | |||
T2组 | 22.0(16.2,32.7) | 32.9(18.4,59.7) | 81.0(63.0,108.5) | 5.4(4.6,7.7) | 7.2(6.2,7.9) | 167.0(142.0,167.0) | 11.7(9.4,14.5) | 4.2(3.7,4.5) | 128.1(113.5,136.3) | |||
T3组 | 22.1(14.6,36.9) | 40.7(22.5,67.2) | 77.0(63.0,103.3) | 6.2(5.3,7.6) | 7.0(6.3,8.6) | 158.0(127.0,194.2) | 10.8(9.1,14.3) | 4.1(3.8,4.6) | 126.9(116.7,139.3) | |||
检验统计量值 | 0.409c | 1.756c | 2.788c | 2.831c | 3.418c | 3.135c | 2.087c | 0.311c | 0.734c | |||
P值 | 0.815 | 0.416 | 0.248 | 0.243 | 0.181 | 0.209 | 0.352 | 0.856 | 0.693 | |||
组别 | 中性粒细胞计数〔M(P25,P75),×109/L〕 | 淋巴细胞计数〔M(P25,P75),×109/L〕 | 单核细胞计数〔M(P25,P75),×109/L〕 | 体外循环时间>4 h〔n(%)〕 | 主动脉阻断时间( | 术前发生灌注不足〔n(%)〕 | 阴离子间隙( | 血K+ 〔M(P25,P75),mmol/L〕 | 血Na+ 〔M(P25,P75),mmol/L〕 | 血Ca2+〔M(P25,P75),mmol/L〕 | ||
总患者 | 9.7(7.5,12.4) | 0.9(0.6,1.2) | 0.7(0.5,0.9) | 74(35.9) | 119.9±20.6 | 53(25.7) | 15.2±3.9 | 4.0(3.4,4.0) | 139.0(136.0,141.0) | 2.2(2.1,2.3) | ||
T1组 | 9.8(7.1,11.8) | 0.9(0.6,1.4) | 0.7(0.5,1.0) | 23(33.3) | 125.6±27.6 | 22(31.9) | 16.1±3.2 | 3.8(3.2,4.0) | 136.0(134.0,139.0) | 2.1(2.0,2.3) | ||
T2组 | 10.1(7.4,12.8) | 0.9(0.6,1.3) | 0.7(0.6,0.9) | 27(38.6) | 119.8±24.3 | 17(24.3) | 15.4±3.9 | 4.0(3.6,4.1) | 139.0(137.0,140.0)d | 2.2(2.1,2.3) | ||
T3组 | 9.6(7.9,12.8) | 0.8(0.6,0.9) | 0.6(0.5,0.9) | 24(35.8) | 121.4±21.1 | 14(20.9) | 14.1±4.4d | 4.0(3.4,4.1) | 140.0(139.0,143.0)d | 2.1(2.0,2.3) | ||
检验统计量值 | 2.350c | 4.241c | 2.441c | 0.415b | 2.601a | 2.263b | 4.387a | 4.383c | 57.384c | 5.782c | ||
P值 | 0.309 | 0.120 | 0.295 | 0.813 | 0.310 | 0.322 | 0.014 | 0.112 | 0.001 | 0.056 |
组别 | 例数 | 30 d内全因死亡率 | 急性肾损伤发生率 | 谵妄发生率 | 急性脑卒中发生率 | 术后二次出血发生率 |
---|---|---|---|---|---|---|
T1组 | 69 | 5(7.2) | 8(11.6) | 4(5.8) | 2(2.9) | 2(2.9) |
T2组 | 70 | 10(14.3)a | 10(14.3) | 8(11.4) | 3(4.3) | 4(5.7) |
T3组 | 67 | 18(26.9)ab | 19(28.4)ab | 5(7.5) | 9(13.4)ab | 4(6.0) |
χ2值 | 9.963 | 7.455 | 1.537 | 7.011 | 0.843 | |
P值 | 0.007 | 0.024 | 0.464 | 0.031 | 0.656 |
Table 2 Comparison of outcomes of three groups within 30 days after operation
组别 | 例数 | 30 d内全因死亡率 | 急性肾损伤发生率 | 谵妄发生率 | 急性脑卒中发生率 | 术后二次出血发生率 |
---|---|---|---|---|---|---|
T1组 | 69 | 5(7.2) | 8(11.6) | 4(5.8) | 2(2.9) | 2(2.9) |
T2组 | 70 | 10(14.3)a | 10(14.3) | 8(11.4) | 3(4.3) | 4(5.7) |
T3组 | 67 | 18(26.9)ab | 19(28.4)ab | 5(7.5) | 9(13.4)ab | 4(6.0) |
χ2值 | 9.963 | 7.455 | 1.537 | 7.011 | 0.843 | |
P值 | 0.007 | 0.024 | 0.464 | 0.031 | 0.656 |
Figure 1 ROC curve analysis of admission serum Cl- and Na+ for predicting postoperative 30-dayall-cause mortality in acute Stanford type A aortic dissection patients
变量 | B | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
年龄 | 0.013 | 0.017 | 0.652 | 0.419 | 1.013(0.981,1.047) |
男性 | 0.204 | 0.397 | 0.263 | 0.608 | 1.226(0.563,2.669) |
高血压 | 0.182 | 0.440 | 0.171 | 0.679 | 1.200(0.506,2.884) |
冠心病 | 0.425 | 0.825 | 0.265 | 0.606 | 1.530(0.304,7.712) |
吸烟 | -3.500 | 0.387 | 0.815 | 0.367 | 0.705(0.330,1.506) |
饮酒 | -0.113 | 0.380 | 0.089 | 0.766 | 0.893(0.424,1.882) |
体温 | -0.258 | 0.371 | 0.485 | 0.486 | 0.772(0.373,4.589) |
心率 | 0.003 | 0.011 | 0.058 | 0.810 | 1.003(0.982,1.024) |
收缩压 | 0.002 | 0.007 | 0.116 | 0.733 | 1.002(0.989,1.016) |
舒张压 | 0.011 | 0.011 | 0.996 | 0.318 | 1.011(0.990,1.032) |
丙氨酸氨基转移酶 | -0.001 | 0.001 | 0.209 | 0.648 | 0.999(0.997,1.002) |
天冬氨酸氨基转移酶 | 0.001 | 0.001 | 0.129 | 0.719 | 1.000(0.998,1.001) |
肌酐 | 0.001 | 0.002 | 0.028 | 0.866 | 1.000(0.995,1.004) |
尿素氮 | -0.010 | 0.052 | 0.034 | 0.853 | 0.990(0.894,1.097) |
血糖 | 0.041 | 0.044 | 0.872 | 0.350 | 1.042(0.956,1.134) |
血小板计数 | 0.002 | 0.003 | 0.029 | 0.865 | 1.000(0.995,1.006) |
白细胞计数 | -0.006 | 0.050 | 0.013 | 0.994 | 0.994(0.901,1.097) |
红细胞计数 | 0.074 | 0.350 | 0.045 | 0.833 | 1.077(0.542,2.140) |
血红蛋白 | -0.003 | 0.012 | 0.048 | 0.827 | 0.997(0.975,1.021) |
中性粒细胞计数 | -0.011 | 0.051 | 0.043 | 0.836 | 0.989(0.895,1.094) |
淋巴细胞计数 | -0.164 | 0.336 | 0.238 | 0.626 | 0.849(0.439,1.641) |
单核细胞计数 | 0.041 | 0.539 | 0.006 | 0.939 | 1.042(0.362,2.995) |
体外循环时间>4 h | 0.476 | 0.385 | 1.534 | 0.216 | 1.610(0.758,3.422) |
术前发生灌注不足 | 1.241 | 0.395 | 9.893 | 0.002 | 3.459(1.596,7.497) |
阴离子间隙 | -0.023 | 0.050 | 0.213 | 0.645 | 0.977(0.886,1.077) |
血Na+ | 0.105 | 0.036 | 8.609 | 0.003 | 1.111(1.036,1.192) |
血K+ | -0.002 | 0.301 | 0.001 | 0.995 | 0.998(0.553,1.801) |
血Ca2+ | -1.508 | 0.968 | 2.425 | 0.119 | 0.221(0.033,1.477) |
血Cl- | 0.151 | 0.041 | 13.544 | <0.001 | 1.163(1.073,1.261) |
Table 3 Univariate Logistic regression analysis of factors associated with postoperative 30-day all-cause mortality in acute Stanford type A aortic dissection patients
变量 | B | SE | Wald χ2值 | P值 | OR(95%CI) |
---|---|---|---|---|---|
年龄 | 0.013 | 0.017 | 0.652 | 0.419 | 1.013(0.981,1.047) |
男性 | 0.204 | 0.397 | 0.263 | 0.608 | 1.226(0.563,2.669) |
高血压 | 0.182 | 0.440 | 0.171 | 0.679 | 1.200(0.506,2.884) |
冠心病 | 0.425 | 0.825 | 0.265 | 0.606 | 1.530(0.304,7.712) |
吸烟 | -3.500 | 0.387 | 0.815 | 0.367 | 0.705(0.330,1.506) |
饮酒 | -0.113 | 0.380 | 0.089 | 0.766 | 0.893(0.424,1.882) |
体温 | -0.258 | 0.371 | 0.485 | 0.486 | 0.772(0.373,4.589) |
心率 | 0.003 | 0.011 | 0.058 | 0.810 | 1.003(0.982,1.024) |
收缩压 | 0.002 | 0.007 | 0.116 | 0.733 | 1.002(0.989,1.016) |
舒张压 | 0.011 | 0.011 | 0.996 | 0.318 | 1.011(0.990,1.032) |
丙氨酸氨基转移酶 | -0.001 | 0.001 | 0.209 | 0.648 | 0.999(0.997,1.002) |
天冬氨酸氨基转移酶 | 0.001 | 0.001 | 0.129 | 0.719 | 1.000(0.998,1.001) |
肌酐 | 0.001 | 0.002 | 0.028 | 0.866 | 1.000(0.995,1.004) |
尿素氮 | -0.010 | 0.052 | 0.034 | 0.853 | 0.990(0.894,1.097) |
血糖 | 0.041 | 0.044 | 0.872 | 0.350 | 1.042(0.956,1.134) |
血小板计数 | 0.002 | 0.003 | 0.029 | 0.865 | 1.000(0.995,1.006) |
白细胞计数 | -0.006 | 0.050 | 0.013 | 0.994 | 0.994(0.901,1.097) |
红细胞计数 | 0.074 | 0.350 | 0.045 | 0.833 | 1.077(0.542,2.140) |
血红蛋白 | -0.003 | 0.012 | 0.048 | 0.827 | 0.997(0.975,1.021) |
中性粒细胞计数 | -0.011 | 0.051 | 0.043 | 0.836 | 0.989(0.895,1.094) |
淋巴细胞计数 | -0.164 | 0.336 | 0.238 | 0.626 | 0.849(0.439,1.641) |
单核细胞计数 | 0.041 | 0.539 | 0.006 | 0.939 | 1.042(0.362,2.995) |
体外循环时间>4 h | 0.476 | 0.385 | 1.534 | 0.216 | 1.610(0.758,3.422) |
术前发生灌注不足 | 1.241 | 0.395 | 9.893 | 0.002 | 3.459(1.596,7.497) |
阴离子间隙 | -0.023 | 0.050 | 0.213 | 0.645 | 0.977(0.886,1.077) |
血Na+ | 0.105 | 0.036 | 8.609 | 0.003 | 1.111(1.036,1.192) |
血K+ | -0.002 | 0.301 | 0.001 | 0.995 | 0.998(0.553,1.801) |
血Ca2+ | -1.508 | 0.968 | 2.425 | 0.119 | 0.221(0.033,1.477) |
血Cl- | 0.151 | 0.041 | 13.544 | <0.001 | 1.163(1.073,1.261) |
变量 | B | SE | Wald χ2值 | P值 | OR(95%CI) | |
---|---|---|---|---|---|---|
年龄 | 0.003 | 0.019 | 0.018 | 0.893 | 1.003(0.966,1.041) | |
男性 | 0.018 | 0.466 | 0.002 | 0.969 | 1.019(0.409,2.539) | |
术前发生灌注不足 | 1.764 | 0.455 | 15.067 | <0.001 | 5.837(2.395,14.226) | |
血Na+ | 0.094 | 0.041 | 5.092 | 0.024 | 1.098(1.012,1.191) | |
血Cl- | 0.155 | 0.050 | 9.498 | 0.002 | 1.168(1.058,1.289) | |
血Cl-水平 | ||||||
T1 | — | — | — | — | 1.000 | |
T2 | 0.629 | 0.618 | 1.033 | 0.309 | 1.875(0.558,6.301) | |
T3 | 1.712 | 0.446 | 14.699 | 0.032 | 3.785(1.121,12.782) | |
血Cl-水平最佳截断值 | ||||||
≤107 mmol/L | — | — | — | — | 1.000 | |
>107 mmol/L | 1.301 | 0.468 | 7.742 | 0.005 | 3.367(1.469,9.186) |
Table 4 Multivariate Logistic regression analysis of factors associated with postoperative 30-day all-cause mortality in acute Stanford type A aortic dissection patients
变量 | B | SE | Wald χ2值 | P值 | OR(95%CI) | |
---|---|---|---|---|---|---|
年龄 | 0.003 | 0.019 | 0.018 | 0.893 | 1.003(0.966,1.041) | |
男性 | 0.018 | 0.466 | 0.002 | 0.969 | 1.019(0.409,2.539) | |
术前发生灌注不足 | 1.764 | 0.455 | 15.067 | <0.001 | 5.837(2.395,14.226) | |
血Na+ | 0.094 | 0.041 | 5.092 | 0.024 | 1.098(1.012,1.191) | |
血Cl- | 0.155 | 0.050 | 9.498 | 0.002 | 1.168(1.058,1.289) | |
血Cl-水平 | ||||||
T1 | — | — | — | — | 1.000 | |
T2 | 0.629 | 0.618 | 1.033 | 0.309 | 1.875(0.558,6.301) | |
T3 | 1.712 | 0.446 | 14.699 | 0.032 | 3.785(1.121,12.782) | |
血Cl-水平最佳截断值 | ||||||
≤107 mmol/L | — | — | — | — | 1.000 | |
>107 mmol/L | 1.301 | 0.468 | 7.742 | 0.005 | 3.367(1.469,9.186) |
Figure 2 Cumulative survivalcurves within 30 days after surgery for acute Stanford type A aortic dissection patients with different admission serum Cl- levels
Figure 4 Cumulative survival curves within 30 days after surgery for acute Stanford type A aortic dissection patients with different admission serum Cl- and Na+ levels
Figure 5 Subgroup analysis for the association of admission serum Cl- and postoperative 30-day all-cause mortality in acute Stanford type A aortic dissection patients
[1] |
|
[2] |
|
[3] |
盛颖. 临床高危特征及疼痛程度预判急性主动脉夹层的作用[J]. 临床急诊杂志,2017,18(5):392-394. DOI:10.13201/j.issn.1009-5918.2017.05.020.
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
黄毕,田力,樊晓寒,等. A型急性主动脉夹层患者入院时血小板计数与住院死亡率的相关性研究[J]. 中国循环杂志,2014,29(10):814-818. DOI:10.3969/j.issn.1000-3614.2014.10.014.
|
[10] |
田力,樊晓寒,朱俊,等. A型急性主动脉夹层患者血浆D-二聚体浓度和住院死亡的关系[J]. 中华高血压杂志,2014,22(2):200. DOI:10.16439/j.cnki.1673-7245.2014.02.030.
|
[11] |
柳叶,李倩,吴小文. 急性Stanford A型主动脉夹层患者术后死亡危险因素分析[J]. 护理实践与研究,2021,18(13):1969-1972. DOI:10.3969/j.issn.1672-9676.2021.13.020.
|
[12] |
顾嘉玺,邵永丰,倪布清,等. 急性Stanford A型主动脉夹层孙氏手术后院内死亡危险因素分析[J]. 南京医科大学学报(自然科学版),2020,40(8):1194-1197. DOI:10.7655/NYDXBNS20200820.
|
[13] |
曾文新,红科,柳学,等. C反应蛋白与白蛋白比值在急性A型主动脉夹层手术患者预后预测中的价值[J]. 中华急诊医学杂志,2016,25(6):764-768. DOI:10.3760/cma.j.issn.1671-0282.2016.06.016.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
谭莉. 血酮测定评估急性胃肠炎患儿脱水和代谢性酸中毒的价值[J]. 西南国防医药,2018,28(12):1204-1207. DOI:10.3969/j.issn.1004-0188.2018.12.025.
|
[22] |
中国医师协会心血管外科分会大血管外科专业委员会. 主动脉夹层诊断与治疗规范中国专家共识[J]. 中华胸心血管外科杂志,2017,33(11):641-654. DOI:10.3760/cma.j.issn.1001-4497.2017.11.001.
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
Standards of medical care in diabetes-2016: summary of revisions[J]. Diabetes Care,2016,39(Suppl 1):S4-5. DOI:10.2337/dc16-S003.
|
[32] |
|
[33] |
|
[34] |
赵宏亮,徐子良,郑敏文. 急性Stanford A型主动脉夹层术后新发脑梗死的危险因素分析[J]. 影像诊断与介入放射学,2020,29(4):243-246. DOI:10.3969/j.issn.1005-8001.2020.04.001.
|
[35] |
|
[36] |
湛镇伊,杨建安,刘银河. 微小RNA在主动脉夹层中差异性表达与发病机制的研究进展[J]. 中国动脉硬化杂志,2019,27(10):910-914. DOI:10.3969/j.issn.1007-3949.2019.10.015.
|
[37] |
|
[38] |
|
[39] |
|
[1] | XUE Chongxiang, LU Xingyu, LIU Zhening, DONG Huijing, ZHENG Yumin, CUI Huijuan. Dynamic Monitoring of Gene Changes and Its Prognostic Value in Lung Cancer Patients [J]. Chinese General Practice, 2023, 26(36): 4527-4534. |
[2] | CUI Xiaona, FENG Ruixia, HAN Yupeng, ZHOU Yaoyao, LIU Xiaojun, LI Jianchao. A Comparative Study on Clinical Effects of Combined Auxiliary Sequence of VA-ECMO and IABP on Acute Myocardial Infarction Complicated with Cardiogenic Shock [J]. Chinese General Practice, 2023, 26(35): 4439-4445. |
[3] | ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129. |
[4] | ZHANG Siyu, ZHOU Yuqiu, DU Xiaohui, WANG Zhengjun. Advances in Duration of Untreated Psychosis and Its Early Intervention [J]. Chinese General Practice, 2023, 26(33): 4110-4117. |
[5] | MENG Jiangtao, YANG Siyu, SUN Lei, LEI Ruining, ZHAO Xiaoxia. Advances in the Prognostic Value of Diffusion Tensor Imaging with Motor Evoked Potential for Motor Function in Cerebral Infarction Patients with Hemiplegia [J]. Chinese General Practice, 2023, 26(32): 4098-4102. |
[6] | YAN Ke, WEI Wanyi, LI Shuguang, YAO Weinan, DONG Jing, WANG Xiaobin, ZHANG Xueyuan, YANG Jie, SHEN Wenbin, ZHU Shuchai. Effect of Consolidation Chemotherapy on Prognosis of StageⅡ-Ⅲ Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Concurrent Chemotherapy and Radio-therapy [J]. Chinese General Practice, 2023, 26(30): 3772-3779. |
[7] | YAN Ke, WEI Wanyi, DENG Wenzhao, SHEN Wenbin, LI Shuguang, DU Xingyu, ZHANG Xueyuan, YANG Jie, ZHU Shuchai. Long-term Prognosis Analysis and Influencing Factors of Concurrent Chemotherapy and Radio-therapy for Cervical and Upper Thoracic Esophageal Squamous Cell Carcinoma [J]. Chinese General Practice, 2023, 26(30): 3785-3790. |
[8] | SHI Xiaoqi, LUO Nandu, HUANG Jiaojiao, DU Zuochen, HUANG Pei, CAO Xiuli, CHEN Yan, HE Zhixu. Correlation between Aspartate Aminotransferase/Alanine Aminotransferase and Prognosis of Hemophagocytic Lymphohistiocytosis in Children [J]. Chinese General Practice, 2023, 26(30): 3801-3808. |
[9] | XU Zhe, ZHANG Jinxia, ZHANG Xiuhong, XIE Kaihong. Relationship between Sleep Duration and All-cause Mortality in Middle-aged and Older Adults [J]. Chinese General Practice, 2023, 26(28): 3507-3512. |
[10] | TANG Shilan, XIE Kexin, LIU Lingyu, QI Tiantian, YANG Yansui. Advances in Rehabilitation Outcomes and Care in Patients with Prolonged Disorders of Consciousness [J]. Chinese General Practice, 2023, 26(27): 3342-3348. |
[11] | SUN Shuaigang, SHENG Xiaoxiao, ZHANG Wenhui, TIAN Huijuan, ZHAI Yaling. The Analysis of Clinicopathological Characters and Short-term Prognosis in Idiopathic Membranous Nephropathy Patients with Immunoglobulin G4 Combined with Other Different Immunoglobulin G Subtypes Deposition [J]. Chinese General Practice, 2023, 26(21): 2632-2638. |
[12] | ZHAO Zewei, KANG Ning, GUO Fengli, WANG Zhongyu, ZHENG Xiangqian. Effect of Aurora Kinase A Expression on Biochemical Cure in Patients after Medullary Thyroid Cancer Resection [J]. Chinese General Practice, 2023, 26(20): 2508-2512. |
[13] | ZHANG Kang, JI Wenshuai, KONG Xinxin, DU Chen, XIE Kai, WANG Haifeng. Predictive Efficacies of SOFA Score, CURB-65 Score and PSI Score for 28-day Mortality in Patients with Severe Pneumonia: a Comparative Study [J]. Chinese General Practice, 2023, 26(18): 2217-2222. |
[14] | WANG Jun, WU Jiafei, WANG Yijing, ZHENG Boyue, WANG Yu, JIANG Chuanyan, LI Hui. Efficacy and Prognostic Effect of Daratumumab-based Chemotherapy Regimen in Multiple Myeloma: a Real-world Study [J]. Chinese General Practice, 2023, 26(18): 2256-2262. |
[15] | MA Yong, GAO Weibo, ZHU Jihong. Risk Factors of Thrombocytopenia Caused by Pyogenic Liver Abscess [J]. Chinese General Practice, 2023, 26(17): 2120-2124. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||